We are live on ! Find out more
TRML

Tourmaline Bio
TRML

Delisted

TRML was delisted on the 27th of October, 2025.

Back to rankings

56 hedge funds and large institutions have $71M invested in Tourmaline Bio in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 13

0.42% less ownership

Funds ownership: 6.97% → 6.55% (-0.42%)

5% less funds holding

Funds holding: 59 → 56 (-3)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

45% less capital invested

Capital invested by funds: $129M → $71M (-$58.2M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
56
Holders Change
-3
Holders Change %
-5.08%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
17
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.14M
2
CCM
CAAS Capital Management
New York
+$1.08M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$354K
4
Millennium Management
Millennium Management
New York
+$194K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$148K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.94M
2
ACM
Aisling Capital Management
New York
-$1.85M
3
HA
HHLR Advisors
Cayman Islands
-$1.2M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$1.03M
5
CAM
Cormorant Asset Management
Massachusetts
-$998K
Name Holding Trade Value Shares
Change 		Change in
Stake
CUAMC
51
China Universal Asset Management Company
China
$1K +$1.42K +39 New
Fidelity Investments
52
Fidelity Investments
Massachusetts
$1K +$1.57K +43 +358%
HA
53
HHLR Advisors
Cayman Islands
– -$1.2M -26,615 Closed
O
54
OrbiMed
New York
– -$1.06K -23,600 Closed
SAM
55
Sectoral Asset Management
Quebec, Canada
– -$1.03M -22,862 Closed
WP
56
Woodline Partners
California
– -$929K -20,606 Closed
N
57
Nuveen
North Carolina
– -$277K -6,152 Closed
Ensign Peak Advisors
58
Ensign Peak Advisors
Utah
– -$193K -4,283 Closed
Tudor Investment Corp
59
Tudor Investment Corp
Connecticut
– -$192K -4,249 Closed
MIM
60
MetLife Investment Management
New Jersey
– -$62.8K -1,392 Closed
VF
61
Virtu Financial
New York
– -$56K -1,240 Closed
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$45.6K -1,012 Closed
BC
63
BIT Capital
Germany
– -$55.5K -747 Closed
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
– -$7.29K -162 Closed
UBS Group
65
UBS Group
Switzerland
– -$4K -83 Closed
Wells Fargo
66
Wells Fargo
California
– -$546 -15 -75%
CS
67
Credit Suisse
Switzerland
– +$401 +11 +550%
1 2
3

TRML Hedge Fund Activity: Q3 2022 in Review

56 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Tourmaline Bio (TRML) for Q3 2022, worth a combined $71M — down 45% from $129M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of TRML and 11 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 17 added.

The largest buyer was Bank of Montreal, adding an estimated $1.14M. The largest seller was BlackRock, cutting an estimated $1.94M.

  • 56 institutional investors held Tourmaline Bio (TRML) as of Q3 2022, down from 59 in Q2 2022.
  • Funds reported $71M of Tourmaline Bio stock for Q3 2022, down 45% quarter-over-quarter.
  • 11 funds opened new Tourmaline Bio positions in Q3 2022 and 13 closed out, a net change of -2 holders.
  • The largest Tourmaline Bio buyer in Q3 2022 was Bank of Montreal, an estimated $1.14M added.
  • The largest Tourmaline Bio seller in Q3 2022 was BlackRock, an estimated $1.94M sold.

Based on aggregated 13F filings for Q3 2022.